tiprankstipranks

Luye Pharma Group Schedules Board Meeting to Approve Annual Results and Dividend

Story Highlights
  • Luye Pharma Group is a pharmaceutical company focusing on innovative medications.
  • The company will hold a board meeting to approve annual results and consider a final dividend.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Luye Pharma Group Schedules Board Meeting to Approve Annual Results and Dividend

Luye Pharma Group ( (HK:2186) ) has provided an announcement.

Luye Pharma Group Ltd. has announced a board meeting scheduled for March 28, 2025, to approve the company’s annual results for the year ending December 31, 2024, and to consider the payment of a final dividend. This meeting is significant as it will determine the company’s financial performance and potential shareholder returns, impacting its market position and stakeholder interests.

More about Luye Pharma Group

Luye Pharma Group Ltd. is a pharmaceutical company engaged in the development, production, and sale of innovative medications. The company operates in the healthcare industry, focusing on providing advanced therapeutic solutions to meet diverse medical needs.

YTD Price Performance: 10.0%

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $1.1B

For a thorough assessment of 2186 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App